Gliacure, Inc. — Form D/A
Gliacure, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2014-08-08. The offering totals $6.0M, of which $5.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-08-08
- Form: D/A
- Accession: 0001543496-14-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.8M
- Remaining: $200K
- Investors: 98
- Date of first sale: 2014-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-217230
Issuer
- Name: Gliacure, Inc.
- CIK: 0001543496
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 234 CAUSEWAY STREET, #809, BOSTON, MA, 02114
- Phone: 617-532-0358
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Philip Haydon | Director | Boston, MA |
| Joseph S Zakrzewski | Director | Denver, CO |
| Philip Haydon | Executive Officer | Boston, MA |
| Yolande S Haydon | Executive Officer | Boston, MA |
| Walter Dewey | Director | Middleton, WI |
| Walter Dewey | Executive Officer | Middleton, WI |
| Michael Szulczewski | Director | Madison, WI |
| Michael Szulczewski | Executive Officer | Madison, WI |
Other filings by this issuer (3)
More